Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lancaster Colony | LANC | Apr 17, 2025 | 189.03 | +3.24 |
Landbridge Company | LB | Apr 17, 2025 | 69.05 | +2.07 |
Landmark Bancorp | LARK | Apr 17, 2025 | 27.73 | +0.65 |
Lands End | LE | Apr 17, 2025 | 9.17 | +1.10 |
Landsea Homes | LSEA | Apr 17, 2025 | 5.93 | +2.77 |
Landstar System | LSTR | Apr 17, 2025 | 137.82 | +2.64 |
Lantern Pharma | LTRN | Apr 17, 2025 | 3.42 | -2.01 |
Lantheus | LNTH | Apr 17, 2025 | 101.32 | +0.80 |
Lantronix | LTRX | Apr 17, 2025 | 2.05 | 0.00 |
Lanvin Group | LANV | Apr 17, 2025 | 2.22 | +0.45 |
Lanzatech Global | LNZA | Apr 17, 2025 | 0.17 | -12.65 |
Largecap Core Alphadex First Trust | FEX | Apr 17, 2025 | 96.34 | +0.74 |
Largecap Dividend Wisdomtree | DLN | Apr 17, 2025 | 74.73 | +0.77 |
Largecap ETF Vanguard | VV | Apr 17, 2025 | 242.47 | +0.25 |
Largecap Growth Opp Alphadex First Trust | FTC | Apr 17, 2025 | 126.39 | +0.40 |
Largecap Value Opp Alphadex First Trust | FTA | Apr 17, 2025 | 71.02 | +0.90 |
Largo | LGO | Apr 17, 2025 | 1.61 | +8.05 |
Larimar Therapeutics | LRMR | Apr 17, 2025 | 1.91 | +3.80 |
Las Vegas Sands | LVS | Apr 17, 2025 | 32.77 | +2.86 |
Laser Photonics | LASE | Apr 17, 2025 | 2.72 | +7.94 |
Latham Group | SWIM | Apr 17, 2025 | 4.91 | +1.66 |
Latin America Alphadex First Trust | FLN | Apr 17, 2025 | 17.92 | +3.17 |
Lattice Semiconductor | LSCC | Apr 17, 2025 | 41.18 | -0.99 |
Launch One Acquisition | LPAA | Apr 17, 2025 | 10.21 | -0.10 |
Launch One Acquisition | LPAAU | Apr 17, 2025 | 10.27 | 0.00 |
Launch Two Acquisition A | LPBB | Apr 17, 2025 | 10.13 | +0.10 |
Launch Two Acquisition Units | LPBBU | Apr 17, 2025 | 10.19 | +0.10 |
Laureate Education | LAUR | Apr 17, 2025 | 19.14 | -1.09 |
LAVA Therapeutics | LVTX | Apr 17, 2025 | 1.31 | +6.50 |
Lavoro | LVRO | Apr 17, 2025 | 3.07 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.